AcuraStem

🚨 Tomorrow:

🚨Just Announced: AcuraStem Associate Vice President of Discovery and Early Development, Wen-Hsuan (Wen) Chang will present "Development of an UNC13A Cryptic Exon Skipping Antisense Oligonucleotide as a Treatment For ALS" at NextGen Biomed by Oxford Global in London, March 12-14, 2025. 🔬Learn about the remarkable progress of our iNeuroRx® platform in advancing disease-modifying therapies for ALS and in advancing our UNC13A program. AcuraStem’s best-in-class ALS models are powering the discovery of translatable therapies that promise to modify disease progression. 👥 Wen will be on hand to discuss potential collaborations on iNeuroRx® and our groundbreaking UNC13A and SYF2 antisense oligonucleotide drug candidates. Visit us at acurastem.com to learn more and join our mission.

We're #hiring a new Associate VP / VP, Clinical Development in Pasadena, California. Apply today or share this post with your network.

We're #hiring a new Senior Research Associate In Vivo in Pasadena, California. Apply today or share this post with your network.

Please be aware of this scam!

Starting today:

🚨 Beware of Fake Job Offers from Scammers Impersonating AcuraStem 🚨 We have been made aware of recent scams where individuals are receiving fake job offers that falsely claim to be from AcuraStem.Please be cautious as these offers may appear legitimate. It’s important to note: AcuraStem does not reach out directly via email or social media to solicit personal information or make job offers. All legitimate AcuraStem job opportunities are posted on our official website and through verified job boards. If you receive any suspicious communication, do not reply or click on any links. Verify all job offers by visiting our official career opportunities page (https://lnkd.in/eKUe5Ktc).

California ALS Summit Recap: At the 15th annual ALS Network Research Summit in San Francisco, AcuraStem Associate Vice President, Discovery and Early Development, Wen-Hsuan (Wen) Chang, presented “Development of an UNC13A ASO for ALS” AcuraStem was proud to once again sponsor the ALS Network Research Summit. Learn more about the event and AcuraStem’s iNeuroRX® technology platform—the gold standard for discovering novel, effective, and broadly-acting treatments—along with our patient-based approach to combating neurodegenerative diseases. Go to 👉 https://pxl.to/hmplpm #ALSSummit #AcuraStem #NeurodegenerativeResearch #iNeuroRX #ALSResearch #UNC13A #CaliforniaScience #BiotechInnovation #PatientDriven #ScienceForGood

AcuraStem is delivering high-impact ALS therapeutics. Join us at the Neuroscience Innovation Pharma Partnering Summit in Boston (Feb 18-19), where CSO Marcel van der Brug will showcase the groundbreaking advancements made possible by our iNeuroRx® platform in the discovery of disease-modifying therapies for ALS and FTD. We’ve already partnered with Takeda on our PIKFYVE program—now we’re advancing UNC13A and SYF2 antisense oligonucleotide drug candidates. AcuraStem’s best-in-class ALS models power the discovery of translatable therapies that modify key disease phenotypes, including survival. 📍 Presentation: “Using the iNeuroRx® Platform to Develop Disease-Modifying Treatments for ALS & FTD” Are you committed to ending ALS? Let’s connect in Boston and explore partnership opportunities. acurastem.com #AcuraStem #EndALS #FTDAwareness #NeuroscienceInnovation #PharmaPartnering #iNeuroRx #DiseaseModifyingTherapies #ALSResearch #BiotechInnovation #JoinUsInBoston

✨Meet our Executive Advisor Wen-Hsuan (Wen) Chang from AcuraStem✨ Interested in joining Women In Bio? You can learn more about WIB membership and gain access to our video library, mentorship opportunities, and more here: https://lnkd.in/eSDv3Tsd #LifeSciencesLA #BiotechLA #HealthTechLA #WomenInSTEM #Networking #WomenInLifeSciences #WomenInBiotech #WomenInPharma #WomenInResearch #WomenInBio #WomenInBioLosAngeles #WIB #WIBLA